Evidence map›Paper›PMID 36198012›Full record

SynthesisClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.

Fang Ma, Li Yuan, Xinli Wen, Yangyang Wang, Qiaofei Li, Chu Chen

Erratum issuedOpen access · goldAbstract readSystematic ReviewNetwork Meta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fang MaShaanxi University of Chinese Medicine, Xian Yang, Shaanxi, ChinaORCID 0000-0002-4099-7218
Li YuanFirst Affiliated Hospital of Xi'an Medical University The First Affiliated Hospital of Xi 'an Jiaotong University, Xi 'an, Shaanxi, ChinaORCID 0000-0002-2981-5655
Xinli WenShaanxi Academy of Traditional Chinese Medicine, Xi'an, Shaanxi, China
Yangyang WangShaanxi University of Chinese Medicine, Xian Yang, Shaanxi, China
Qiaofei LiShaanxi University of Chinese Medicine, Xian Yang, Shaanxi, China
Chu ChenShaanxi Academy of Traditional Chinese Medicine, Xi'an, Shaanxi, ChinaORCID 0000-0002-2280-4523
Shaanxi University of Chinese Medicine · CNJilin Academy of Traditional Chinese Medicine · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct Oral Anticoagulants (DOACs) , which partially replace warfarin, have been developed as a safe and effective therapy for patients with stable coronary artery disease (SCAD) and atrial fibrillation (AF). However, the choice of DOACs and warfarin remains controversial. We conducted a network meta-analysis (NMA) using randomized controlled trials (RCTs) through a systematic literature review to evaluate the the efficacy and safety of DOACs in SCAD and AF patients. Five RCTs with 6524 patients were included. The results showed that patients taking DOACs had a lower risk of stroke/systemic embolism (OR, 0.64; 95% CI, 0.54-0.76,

Indexed as

Atrial FibrillationCoronary Artery DiseaseEmbolismStrokeAdministration, OralAnticoagulantsHemorrhageHumansRivaroxabanWarfarinAnticoagulantsRivaroxabanWarfarinatrial fibrillationdirect oral anticoagulantsnetwork meta-analysisstable coronary artery disease

Identifiers

PMID36198012
PMCPMC9537486
OpenAlexW4302760924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.